Nicotine Cessation Therapy

First-Line Treatment Options

The National Comprehensive Cancer Network recommends combination nicotine replacement therapy (nicotine patch plus a short-acting NRT) or varenicline, along with behavioral counseling, as first-line treatment for patients requiring nicotine cessation therapy 1, 2
Standard dosing for combination nicotine replacement therapy is 21 mg patch plus short-acting NRT for 12 weeks 1
If 21 mg patch is not effective, consider increasing to 35 or 42 mg patch 1
Blood nicotine levels from NRT are significantly less than from smoking cigarettes, making toxicity rare even when used with smoking 1
Varenicline should be initiated 1-2 weeks prior to quit date 1
Contraindicated for patients with brain metastases due to seizure risk 1

Bupropion can be used with or without NRT for 7-12 weeks 1
Monitor for neuropsychiatric side effects when using bupropion or varenicline 1
Varenicline (2 mg/day) has shown the highest 6-month abstinence rate at 33.2% compared to other monotherapies 3
Combination NRT with long-term patch plus gum or spray shows abstinence rates of 36.5% at 6 months 3
Bupropion SR shows abstinence rates of 24.2% at 6 months 3

The National Comprehensive Cancer Network recommends at least 4 sessions of behavioral therapy during each 12-week course of pharmacotherapy 4, 5
Session duration should be 10-30+ minutes 5
Skills training, social support, and motivational interviewing should be included in behavioral therapy 1, 4
Addressing smoking triggers and coping strategies is essential in behavioral therapy 4

In-person or phone follow-up should be done within 2 weeks after starting pharmacotherapy and at minimum 12-week intervals 1
Continued follow-up after completion of therapy is crucial for monitoring progress and adjusting treatment 1
If initial quit attempt fails, try a first-line medication not previously used or use combination therapy if monotherapy failed 6, 7
Consider longer course of treatment (6 months to 1 year) or increased dose of NRT if standard dose was ineffective 1, 6
Progressively intensify behavioral therapy with referral to specialty care as needed 1

Nicotine withdrawal symptoms typically peak within 1-2 weeks of quitting and then subside 1, 4
Track attempts at smoking reduction; if reduction efforts stall, consider switching to a different pharmacotherapy 1
Patients who do not quit immediately may quit later after withdrawal symptoms subside 1

Providing pharmacotherapy without behavioral support significantly reduces effectiveness 4
Inadequate dosing or premature discontinuation of therapy can reduce success rates 6
Failure to address psychiatric comorbidities that may affect cessation success can reduce effectiveness 4
Not offering alternative treatments after failed quit attempts can reduce success rates 6
Neglecting follow-up is crucial for monitoring progress and adjusting treatment 1